Replies to post #226370 on Biotech Values

[DewDiligence]

RARX -9.5% to $40.51 despite all-cash buyout by UCB.BR at $48/sh, scheduled for closing on or around Mar 30:

https://www.sec.gov/Archives/edgar/data/1481512/000110465920027201/tm2011310-1_8k.htm

Either the market has become thoroughly dysfunctional…or somebody knows something non-public about this deal.

[DewDiligence]

UCB.BR closes acquisition of RARX for $48/sh in cash:

https://www.sec.gov/Archives/edgar/data/1481512/000110465920042433/tm2014471d1_ex99-1.htm